Literature DB >> 17805968

Fucoidin prevents Clostridium difficile toxin-A-induced ileal enteritis in mice.

A R F Barreto1, I C Cavalcante, M V Castro, A F T A Junqueira, M R Vale, R A Ribeiro, M H L P Souza, G A C Brito.   

Abstract

Recent reports suggest increased incidence and severity of Clostridium difficile-associated diseases. These facts have raised the need for additional clarification of pathogenesis and for a search for new therapeutic strategies. This study evaluated the effects of the polysaccharide fucoidin, an L-selectin blocker, on toxin-A-induced mouse enteritis. Fucoidin (25 mg/kg) or saline (0.1 ml) were injected systemically (ocular plexus) 5 min prior to local challenge with toxin A (5 microg/ileal loop) or phosphate-buffered saline (PBS). Intestinal fluid volume/length and ileal loop weight/length ratios were calculated 3 h later. Ileal tissues were collected for histopathology and measurement of myeloperoxidase and adenosine deaminase activity. Fucoidin significantly (P < 0.05) prevented the toxin-A-induced increase in weight/length and volume/length ratios and reduced mucosal disruption, as shown in histopathology. Fucoidin also significantly (P < 0.05) reduced toxin-A-induced myeloperoxidase and adenosine deaminase activities. In conclusion, fucoidin reduces tissue injury and inflammation in toxin-A-induced mouse enteritis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805968     DOI: 10.1007/s10620-007-9957-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  48 in total

1.  Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis.

Authors:  R A Sari; S Taysi; O Yilmaz; N Bakan
Journal:  Clin Exp Rheumatol       Date:  2003 Jan-Feb       Impact factor: 4.473

2.  A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes.

Authors:  M Catherine McEllistrem; Robert J Carman; Dale N Gerding; C W Genheimer; L Zheng
Journal:  Clin Infect Dis       Date:  2004-12-15       Impact factor: 9.079

Review 3.  Clostridium difficile colitis.

Authors:  C P Kelly; C Pothoulakis; J T LaMont
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

4.  Biological activities of toxins A and B of Clostridium difficile.

Authors:  D M Lyerly; D E Lockwood; S H Richardson; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

5.  Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis.

Authors:  M A Piras; C Gakis; M Budroni; G Andreoni
Journal:  Br Med J       Date:  1978 Dec 23-30

6.  Clostridium difficile toxin A-induced microvascular dysfunction. Role of histamine.

Authors:  I Kurose; C Pothoulakis; J T LaMont; D C Anderson; J C Paulson; M Miyasaka; R Wolf; D N Granger
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Modulation of lipopolysaccharide-induced monocyte activation by heparin-binding protein and fucoidan.

Authors:  M Heinzelmann; H C Polk; F N Miller
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Decreased gastric tone and delayed gastric emptying precede neutrophil infiltration and mucosal lesion formation in indomethacin-induced gastric damage in rats.

Authors:  M H L P Souza; L E A Troncon; F Q Cunha; R B Oliveira
Journal:  Braz J Med Biol Res       Date:  2003-09-16       Impact factor: 2.590

9.  Cecal toxin(s) from guinea pigs with clindamycin-associated colitis, neutralized by Clostridium sordellii antitoxin.

Authors:  J E Rehg
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

10.  The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins.

Authors:  I Just; M Wilm; J Selzer; G Rex; C von Eichel-Streiber; M Mann; K Aktories
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

View more
  3 in total

1.  Adenosine deaminase inhibition prevents Clostridium difficile toxin A-induced enteritis in mice.

Authors:  Ana Flávia Torquato de Araújo Junqueira; Adriana Abalen Martins Dias; Mariana Lima Vale; Graziela Machado Gruner Turco Spilborghs; Aline Siqueira Bossa; Bruno Bezerra Lima; Alex Fiorini Carvalho; Richard Littleton Guerrant; Ronaldo Albuquerque Ribeiro; Gerly Anne Brito
Journal:  Infect Immun       Date:  2010-11-29       Impact factor: 3.441

2.  Emergence of an outbreak-associated Clostridium difficile variant with increased virulence.

Authors:  Carlos Quesada-Gómez; Diana López-Ureña; Luis Acuña-Amador; Manuel Villalobos-Zúñiga; Tim Du; Rosemayre Freire; Caterina Guzmán-Verri; María del Mar Gamboa-Coronado; Trevor D Lawley; Edgardo Moreno; Michael R Mulvey; Gerly Anne de Castro Brito; Evelyn Rodríguez-Cavallini; César Rodríguez; Esteban Chaves-Olarte
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

3.  New advances in the treatment of Clostridium difficile infection (CDI).

Authors:  Dennis D Hedge; Joe D Strain; Jodi R Heins; Debra K Farver
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.